Ignite Creation Date:
2024-05-06 @ 6:15 PM
Last Modification Date:
2024-10-26 @ 2:44 PM
Study NCT ID:
NCT05596266
Status:
RECRUITING
Last Update Posted:
2022-10-27
First Post:
2022-10-23
Brief Title:
CD5 CAR-T Therapy for RefractoryRelapsed CD5 T-cell Acute Lymphoblastic Leukemia
Sponsor:
Xuanwu Hospital Beijing
Organization:
Xuanwu Hospital Beijing
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-25
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-25
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-23
First Submit QC Date:
October 23 2022
Study First Post Date:
2022-10-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-23
Last Update Post Date:
2022-10-27
Last Update Post Date Type:
ACTUAL